Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | ADAM9 |
| Upstream (Parents) |
|---|
| (<<) CHST7 → ADAM9 |
| (<<) CLEC2B → ADAM9 |
| (<<) GPNMB → ADAM9 |
| (<<) GPRIN2 → ADAM9 |
| (<<) HDAC2 → ADAM9 |
| (<<) IMPA1 → ADAM9 |
| (<<) LYPLA2 → ADAM9 |
| (<<) MAP3K11 → ADAM9 |
| (<<) NNMT → ADAM9 |
| (<<) PLA2G6 → ADAM9 |
| (<<) RAB5C → ADAM9 |
| (<<) RECK → ADAM9 |
| (<<) SPRR1A → ADAM9 |
| (<<) UBE2E3 → ADAM9 |
| (<<) UBQLN2 → ADAM9 |
| (<<) VEGFA → ADAM9 |
| (<<) WBP4 → ADAM9 |
| (<<) YWHAB → ADAM9 |
| Downstream (Children) |
|---|
| ADAM9 → BCL6 (>>) |
| ADAM9 → EIF4EBP1 (>>) |
| ADAM9 → FHIT (>>) |
| ADAM9 → LSM1 (>>) |
| ADAM9 → STAT6 (>>) |
| ADAM9 → TCEB1 (>>) |
| ADAM9 → ZNF467 (>>) |
